UP!

HTWR $57.98

HTWR target price
57.98
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2016-07-11 Downgrade Leerink Swann Outperform to Market Perform
2016-06-29 Downgrade BTIG Research Buy to Neutral
2016-06-29 Downgrade Wells Fargo Outperform to Market Perform
2016-06-29 Downgrade Barclays Overweight to Equal Weight $35.00 to $58.00
2016-06-29 Downgrade Wells Fargo & Co. Outperform to Market Perform
2016-06-29 Downgrade Barclays PLC Overweight to Equal Weight $35.00 to $58.00
2016-06-28 Downgrade SunTrust Buy to Neutral $60.00 to $58.00
2016-06-28 Downgrade SunTrust Banks Inc. Buy to Neutral $60.00 to $58.00
2016-06-27 Reiterated Rating Canaccord Genuity Buy $45.00 to $66.00
2016-06-08 Initiated Coverage Guggenheim Neutral
2016-05-10 Reiterated Rating BTIG Research Buy $50.00 to $45.00
2016-05-05 Lower Price Target Barclays Overweight $42.00 to $35.00
2016-05-05 Lower Price Target Leerink Swann Outperform $45.00 to $40.00
2016-04-30 Reiterated Rating Canaccord Genuity Buy
2016-04-25 Reiterated Rating Bank of America Buy
2016-04-25 Reiterated Rating Bank of America Corp. Buy
2016-03-28 Lower Price Target Raymond James Outperform $43.00 to $42.00
2016-03-28 Lower Price Target Raymond James Financial Inc. Outperform $43.00 to $42.00
2016-03-24 Upgrade Bank of America Neutral to Buy
2016-03-02 Lower Price Target BTIG Research Buy $70.00 to $50.00
2016-02-27 Reiterated Rating Northland Securities Hold
2016-02-26 Lower Price Target Leerink Swann Outperform $60.00 to $45.00
2016-02-26 Lower Price Target Northland Securities Market Perform $45.00 to $35.00
2016-01-31 Reiterated Rating William Blair Market Perform
2016-01-28 Upgrade Wells Fargo Market Perform to Outperform
2016-01-28 Upgrade Raymond James Market Perform to Outperform
2016-01-28 Reiterated Rating Canaccord Genuity Buy $70.00
2016-01-28 Reiterated Rating BTIG Research Buy $70.00
2016-01-14 Reiterated Rating BTIG Research Buy $70.00
2016-01-13 Reiterated Rating Leerink Swann Outperform $60.00
2016-01-13 Reiterated Rating Oppenheimer Market Perform
2016-01-13 Reiterated Rating Oppenheimer Holdings Inc. Market Perform
2016-01-12 Reiterated Rating Canaccord Genuity Buy $70.00
2016-01-12 Reiterated Rating Sterne Agee CRT Buy $60.00 to $55.00
2016-01-12 Downgrade JPMorgan Chase & Co. Overweight to Neutral $56.00 to $39.00
2016-01-07 Reiterated Rating BTIG Research Buy $70.00
2016-01-04 Reiterated Rating Northland Securities Hold $45.00
2015-12-08 Initiated Coverage SunTrust Buy $80.00
2015-11-13 Boost Price Target Goldman Sachs $41.00 to $45.00
2015-11-13 Boost Price Target Goldman Sachs Group Inc. $41.00 to $45.00
2015-11-08 Reiterated Rating Canaccord Genuity Buy $70.00
2015-11-05 Reiterated Rating BTIG Research Buy $70.00
2015-10-30 Downgrade Piper Jaffray Overweight to Neutral $48.00 to $44.00
2015-10-30 Lower Price Target Leerink Swann $63.00 to $60.00
2015-10-30 Downgrade Piper Jaffray Cos. Overweight to Neutral $48.00 to $44.00
2015-10-28 Boost Price Target Credit Suisse $34.00 to $48.00
2015-10-28 Reiterated Rating Canaccord Genuity Buy $70.00
2015-10-28 Boost Price Target Credit Suisse Group AG $34.00 to $48.00
2015-10-26 Upgrade BTIG Research Neutral to Buy $80.00
2015-10-14 Lower Price Target Sterne Agee CRT $93.00 to $60.00
2015-10-14 Upgrade Goldman Sachs Sell to Neutral $67.00 to $42.00
2015-10-14 Reiterated Rating Canaccord Genuity Buy $106.00
2015-10-13 Reiterated Rating Piper Jaffray Buy $86.00 to $48.00
2015-10-13 Reiterated Rating Leerink Swann Buy $85.00 to $63.00
2015-10-13 Downgrade Oppenheimer Outperform to Market Perform
2015-10-13 Lower Price Target Northland Securities Market Perform $60.00 to $45.00
2015-10-02 Upgrade Capital Ideas Research Underperform to Marketperform
2015-10-01 Upgrade Northland Securities Under Perform to Market Perform $60.00
2015-09-28 Reiterated Rating Leerink Swann Outperform $85.00
2015-09-25 Reiterated Rating Canaccord Genuity Buy $106.00
2015-09-15 Reiterated Rating Canaccord Genuity Buy
2015-09-09 Reiterated Rating Canaccord Genuity Buy $106.00
2015-09-08 Reiterated Rating Leerink Swann Outperform $110.00 to $85.00
2015-09-06 Reiterated Rating William Blair Market Perform
2015-09-02 Reiterated Rating Northland Securities Sell $60.00
2015-09-02 Reiterated Rating Canaccord Genuity Buy $106.00
2015-09-02 Reiterated Rating Oppenheimer Buy $100.00
2015-09-02 Downgrade Raymond James Outperform to Market Perform
2015-09-02 Downgrade BTIG Research Buy to Neutral
2015-09-02 Lower Price Target Sterne Agee CRT Buy $103.00 to $93.00
2015-08-27 Lower Price Target Goldman Sachs $81.00 to $78.00
2015-08-10 Reiterated Rating Credit Suisse Buy
2015-08-09 Reiterated Rating BTIG Research Buy $105.00
2015-08-03 Reiterated Rating Piper Jaffray Buy $100.00 to $108.00
2015-08-03 Boost Price Target Leerink Swann Outperform $90.00 to $110.00
2015-07-31 Boost Price Target Barclays Overweight $100.00 to $105.00
2015-07-31 Boost Price Target Oppenheimer Outperform $94.00 to $100.00
2015-07-30 Reiterated Rating Canaccord Genuity Buy $106.00
2015-07-30 Reiterated Rating BTIG Research Buy $90.00
2015-07-28 Boost Price Target JPMorgan Chase & Co. Overweight $85.00 to $104.00
2015-07-23 Reiterated Rating Northland Securities Sell
2015-07-20 Reiterated Rating BTIG Research Buy $90.00
2015-07-15 Lower Price Target Northland Securities Under Perform $70.00 to $60.00
2015-05-09 Reiterated Rating Sterne Agee CRT Buy $109.00 to $103.00
2015-05-08 Reiterated Rating Canaccord Genuity Buy $50.00
2015-05-08 Lower Price Target JPMorgan Chase & Co. Overweight $101.00 to $85.00
2015-05-01 Lower Price Target Barclays Overweight $105.00 to $100.00
2015-04-20 Lower Price Target Oppenheimer Outperform $98.00 to $94.00
2015-04-16 Lower Price Target Canaccord Genuity Buy $110.00 to $106.00
2015-04-01 Reiterated Rating Canaccord Genuity Buy $110.00
2015-02-27 Set Price Target Canaccord Genuity Buy $115.00 to $110.00
2015-02-27 Boost Price Target Leerink Swann Outperform $90.00 to $105.00
2015-02-23 Set Price Target Canaccord Genuity Buy $115.00 to $110.00
2015-02-02 Boost Price Target JPMorgan Chase & Co. Overweight $93.00 to $103.00
2014-11-06 Reiterated Rating JPMorgan Chase & Co. Overweight $100.00 to $93.00
2014-10-31 Reiterated Rating Oppenheimer Outperform $112.00 to $98.00
2014-10-31 Reiterated Rating Canaccord Genuity Buy $125.00 to $115.00
2014-10-14 Upgrade Piper Jaffray Neutral to Overweight $91.00
2014-08-01 Reiterated Rating JPMorgan Chase & Co. Overweight $128.00 to $125.00
2014-08-01 Lower Price Target Leerink Swann $120.00 to $105.00
2014-05-02 Reiterated WallachBeth Buy $110 to $125
2014-05-02 Boost Price Target WallachBeth Capital Buy $110.00 to $125.00
2014-05-02 Boost Price Target Oppenheimer Outperform $103.00 to $112.00
2014-05-02 Boost Price Target Canaccord Genuity $121.00 to $125.00
2014-04-14 Upgrade Oppenheimer Market Perform to Outperform
2014-04-14 Upgrade BTIG Research Neutral to Buy $100.00
2014-04-14 Downgrade Goldman Sachs Neutral to Sell $94.00 to $73.00
2014-02-27 Boost Price Target Canaccord Genuity $115.00 to $121.00
2014-02-20 Initiated Coverage BTIG Research Neutral
2014-01-09 Reiterated Rating Barclays Overweight $100.00 to $110.00
2013-12-16 Boost Price Target JPMorgan Chase & Co. $125.00 to $131.00
2013-12-03 Boost Price Target Canaccord Genuity $110.00 to $115.00
2013-11-26 Initiated Coverage CRT Capital Buy $109.00
2013-10-07 Reiterated Rating Canaccord Genuity Buy $110.00
2013-10-07 Lower Price Target Oppenheimer Market Perform $95.00 to $89.00
2013-04-30 Reiterated Northland Capital Under Perform $60 to $70
2013-03-12 Reiterated UBS Neutral $95 to $87
2012-11-27 Reiterated UBS Neutral $95 to $88
2012-11-12 Reiterated UBS Buy $110 to $100
2012-04-23 Upgrade Barclays Equal Weight to Overweight $80 to $80
2012-01-17 Downgrade Morgan Keegan Outperform to Mkt Perform
2011-05-03 Initiated Wunderlich Hold $80
2011-04-11 Downgrade Auriga U.S.A Buy to Hold $101 to $80
2016-07-11 Downgrade Leerink Swann Outperform to Market Perform
2016-06-29 Downgrade BTIG Research Buy to Neutral
2016-06-29 Downgrade Wells Fargo Outperform to Market Perform
2016-06-29 Downgrade Barclays Overweight to Equal Weight $35.00 to $58.00
2016-06-29 Downgrade Wells Fargo & Co. Outperform to Market Perform

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In HTWR 1 funds of 2213 total. Show all

Fund name Ticker shares
SHAPIRO ROBERT N 1000

Major Shareholders

Name Relationship Total Shares Holding stocks
ADAGE CAPITAL PARTNERS GP LLC 10.13%  (1722969) ADXS / AMAG / BDBD / CALA / FPRX / HTWR / IGOI / PBYI / PSUN / PTGX /
Harrison Seth Loring 0.78%  (133393) HTWR / TKAI /
Godshall Douglas Evan President & Chief Exec Officer 0.50%  (84345) HTWR / PSDV / VTL /
MCAREE PETER F SVP, CFO and Treasurer 0.11%  (19005) HTWR /
Stockman Robert Bernard 0.10%  (17814) HTWR /
Knopf Lawrence J General Counsel 0.10%  (17608) HTWR /
LaRose Jeffrey Chief Scientific Officer 0.07%  (12482) HTWR /
Schuermann James SVP, Sales & Marketing 0.07%  (12043) HTWR /
BARBERICH TIMOTHY J 0.07%  (11107) DARA / HTWR / TKAI / VSTM /
Yocher Robert E SVP, Regulatory & Quality 0.06%  (9839) HTWR /
LARKIN C RAYMOND JR 0.05%  (8000) ALGN / HTWR /
Wade Denis Newell 0.03%  (5750) HTWR /
FELDMANN CYNTHIA L 0.03%  (4750) HGR / HTWR / STE / UFPT /
Thomas Robert Bain 0.03%  (4510) HTWR /
Strong Mark Senior VP, R&D and Quality 0.02%  (3513) HTWR /
OESTERLE STEPHEN N 0.01%  (1000) BAX / HTWR /